Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 29Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Triple Negative Breast Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 8Neoplasm Metastasis 7Esophageal Squamous Cell Carcinoma 7Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ovarian Neoplasms 4Biliary Tract Neoplasms 4Head and Neck Neoplasms 3Gallbladder Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Pancreatic Ductal 3Vaccinia 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms by Site 2Neoplasms 2Locally Advanced Pancreatic Cancer 2Gastrointestinal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Ureteral Neoplasms 1Thyroid Neoplasms 1Squamous Non-small Cell Lung Cancer 1

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Histiocytosis × 130-nm albumin-bound paclitaxel × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡